B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ADENOSINE

MOLECULAR TARGET

Adenosine receptor A3 (human)

UniProt: P0DMS823 compounds

ADENOSINE (Adenosine receptor A3 (human)) is targeted by 23 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ADENOSINE

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Adenosine3.7642
22-Chloroadenosine 2-Chloroadenosine.2.8316
3Nisoldipine1.795
4Clotrimazole1.614
5Econazole1.614
6Hexachlorophene1.614
7Miconazole1.614
817-alpha-Hydroxyprogesterone1.102
9Azacitidine1.102
10Azacitidine1.102
11Disulfiram1.102
12Fenofibrate1.102
13Flunarizine Flunarizine is1.102
14Methylcholanthrene1.102
15Nocodazole Nocodazole is1.102
16Stanozolol1.102
17sulindac sulfide1.102
18Triiodothyronine1.102
19Troglitazone1.102
20Adenosine Monophosphate Adenine nucleotide containing0.691
21Danazol0.691
22Nitrendipine0.691
23Pentostatin0.691

About ADENOSINE as a Drug Target

ADENOSINE (Adenosine receptor A3 (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 23 compounds with documented ADENOSINE interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ADENOSINE inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.